Cargando…
Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming
INTRODUCTION: Vascular leakage plays a vital role in sepsis-induced multi-organ dysfunction. Currently, no specific measures are available for vascular leakage. Ferroptosis, as a recently recognized form of cell death, plays a crucial role in cell dysfunction. It is still unknown whether ferroptosis...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670891/ https://www.ncbi.nlm.nih.gov/pubmed/34916824 http://dx.doi.org/10.2147/JIR.S340420 |
_version_ | 1784615050827268096 |
---|---|
author | She, Han Hu, Yi Zhou, Yuanqun Tan, Lei Zhu, Yu Ma, Chunhua Wu, Yue Chen, Wei Wang, Li Zhang, Zisen Wang, Li Liu, Liangming Li, Tao |
author_facet | She, Han Hu, Yi Zhou, Yuanqun Tan, Lei Zhu, Yu Ma, Chunhua Wu, Yue Chen, Wei Wang, Li Zhang, Zisen Wang, Li Liu, Liangming Li, Tao |
author_sort | She, Han |
collection | PubMed |
description | INTRODUCTION: Vascular leakage plays a vital role in sepsis-induced multi-organ dysfunction. Currently, no specific measures are available for vascular leakage. Ferroptosis, as a recently recognized form of cell death, plays a crucial role in cell dysfunction. It is still unknown whether ferroptosis participates in the occurrence of organ dysfunction following sepsis. Our previous study showed that dexmedetomidine (Dex) could alleviate sepsis-induced organ dysfunction. However, whether the mechanism is related to ferroptosis is not clear. METHODS: The publicly available datasets of septic patients were reanalyzed, and septic models in vivo and vitro by cecal ligation and puncture and lipopolysaccharide-stimulated vascular endothelial cells (VECs) were applied. The occurrence of ferroptosis in septic patients and rats was observed, and the protective effects of Dex on ferroptosis, and related mechanisms on regulating metabolic reprogramming and mitochondrial fission were further studied. RESULTS: The transcriptomics data of patients from the GEO database showed that ferroptosis was closely related to sepsis. Sepsis induced significant ferroptosis in VECs by metabolomics analysis. The level of lipid peroxidation was increased in VECs, and the mitochondrial cristae was decreased after sepsis. Metabolomics analysis showed that Dex activated the pentose phosphate pathway and increased glutathione in VECs via up-regulation of G6PD expression. Dex could antagonize sepsis-induced the decrease in the level of Nrf2. The Nrf2 inhibitor reversed the protective effect of Dex on ferroptosis. Further study showed that Dex significantly alleviated sepsis-induced mitochondrial over-division, improved mitochondrial function, and decreased ROS, further inhibiting the ferroptosis of VECs. Dex alleviated the permeability of vessels by reducing ferroptosis and enhanced the intercellular junction of VECs. CONCLUSION: Dex protects vascular leakage following sepsis by inhibiting ferroptosis. The mechanism is mainly related to metabolic reprogramming via Nrf2 up-regulation and inhibition of mitochondrial fission. |
format | Online Article Text |
id | pubmed-8670891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-86708912021-12-15 Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming She, Han Hu, Yi Zhou, Yuanqun Tan, Lei Zhu, Yu Ma, Chunhua Wu, Yue Chen, Wei Wang, Li Zhang, Zisen Wang, Li Liu, Liangming Li, Tao J Inflamm Res Original Research INTRODUCTION: Vascular leakage plays a vital role in sepsis-induced multi-organ dysfunction. Currently, no specific measures are available for vascular leakage. Ferroptosis, as a recently recognized form of cell death, plays a crucial role in cell dysfunction. It is still unknown whether ferroptosis participates in the occurrence of organ dysfunction following sepsis. Our previous study showed that dexmedetomidine (Dex) could alleviate sepsis-induced organ dysfunction. However, whether the mechanism is related to ferroptosis is not clear. METHODS: The publicly available datasets of septic patients were reanalyzed, and septic models in vivo and vitro by cecal ligation and puncture and lipopolysaccharide-stimulated vascular endothelial cells (VECs) were applied. The occurrence of ferroptosis in septic patients and rats was observed, and the protective effects of Dex on ferroptosis, and related mechanisms on regulating metabolic reprogramming and mitochondrial fission were further studied. RESULTS: The transcriptomics data of patients from the GEO database showed that ferroptosis was closely related to sepsis. Sepsis induced significant ferroptosis in VECs by metabolomics analysis. The level of lipid peroxidation was increased in VECs, and the mitochondrial cristae was decreased after sepsis. Metabolomics analysis showed that Dex activated the pentose phosphate pathway and increased glutathione in VECs via up-regulation of G6PD expression. Dex could antagonize sepsis-induced the decrease in the level of Nrf2. The Nrf2 inhibitor reversed the protective effect of Dex on ferroptosis. Further study showed that Dex significantly alleviated sepsis-induced mitochondrial over-division, improved mitochondrial function, and decreased ROS, further inhibiting the ferroptosis of VECs. Dex alleviated the permeability of vessels by reducing ferroptosis and enhanced the intercellular junction of VECs. CONCLUSION: Dex protects vascular leakage following sepsis by inhibiting ferroptosis. The mechanism is mainly related to metabolic reprogramming via Nrf2 up-regulation and inhibition of mitochondrial fission. Dove 2021-12-10 /pmc/articles/PMC8670891/ /pubmed/34916824 http://dx.doi.org/10.2147/JIR.S340420 Text en © 2021 She et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research She, Han Hu, Yi Zhou, Yuanqun Tan, Lei Zhu, Yu Ma, Chunhua Wu, Yue Chen, Wei Wang, Li Zhang, Zisen Wang, Li Liu, Liangming Li, Tao Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming |
title | Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming |
title_full | Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming |
title_fullStr | Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming |
title_full_unstemmed | Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming |
title_short | Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming |
title_sort | protective effects of dexmedetomidine on sepsis-induced vascular leakage by alleviating ferroptosis via regulating metabolic reprogramming |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670891/ https://www.ncbi.nlm.nih.gov/pubmed/34916824 http://dx.doi.org/10.2147/JIR.S340420 |
work_keys_str_mv | AT shehan protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT huyi protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT zhouyuanqun protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT tanlei protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT zhuyu protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT machunhua protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT wuyue protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT chenwei protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT wangli protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT zhangzisen protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT wangli protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT liuliangming protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming AT litao protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming |